A080720 Stock Overview
Engages in the research, development, production, and sale of prescription drugs in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Union Korea Pharm Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,300.00 |
| 52 Week High | ₩6,460.00 |
| 52 Week Low | ₩3,855.00 |
| Beta | 0.14 |
| 11 Month Change | -4.50% |
| 3 Month Change | -5.36% |
| 1 Year Change | 6.32% |
| 33 Year Change | -58.75% |
| 5 Year Change | -55.83% |
| Change since IPO | -72.82% |
Recent News & Updates
Union Korea Pharm Co., Ltd.'s (KOSDAQ:080720) 26% Share Price Plunge Could Signal Some Risk
Jul 22
Is Union Korea Pharm (KOSDAQ:080720) A Risky Investment?
Apr 23Recent updates
Union Korea Pharm Co., Ltd.'s (KOSDAQ:080720) 26% Share Price Plunge Could Signal Some Risk
Jul 22Is Union Korea Pharm (KOSDAQ:080720) A Risky Investment?
Apr 23Union Korea Pharm (KOSDAQ:080720) Is Carrying A Fair Bit Of Debt
Jan 27
What Percentage Of Union Korea Pharm Co., Ltd. (KOSDAQ:080720) Shares Do Insiders Own?
Dec 22The Union Korea Pharm (KOSDAQ:080720) Share Price Has Gained 38% And Shareholders Are Hoping For More
Nov 17Shareholder Returns
| A080720 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 2.1% | 5.1% | -0.5% |
| 1Y | 6.3% | 21.0% | 0.6% |
Return vs Industry: A080720 underperformed the KR Pharmaceuticals industry which returned 23.1% over the past year.
Return vs Market: A080720 exceeded the KR Market which returned 1% over the past year.
Price Volatility
| A080720 volatility | |
|---|---|
| A080720 Average Weekly Movement | 9.7% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in KR Market | 12.1% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A080720's share price has been volatile over the past 3 months.
Volatility Over Time: A080720's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | 197 | n/a | www.ukp.co.kr |
Union Korea Pharm Co., Ltd. engages in the research, development, production, and sale of prescription drugs in South Korea. It offers pharmaceuticals in various formulations, including tablets, capsules, and injections in the areas of cardiovascular, gastrointestinal, muscular skeletal, antibiotics, etc. The company was formerly known as Union Pharmaceutical Co., Ltd. and changed its name to Union Korea Pharm Co., Ltd.
Union Korea Pharm Co., Ltd. Fundamentals Summary
| A080720 fundamental statistics | |
|---|---|
| Market cap | ₩38.32b |
| Earnings (TTM) | -₩22.78b |
| Revenue (TTM) | ₩64.22b |
0.6x
P/S Ratio-1.7x
P/E RatioIs A080720 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A080720 income statement (TTM) | |
|---|---|
| Revenue | ₩64.22b |
| Cost of Revenue | ₩40.91b |
| Gross Profit | ₩23.31b |
| Other Expenses | ₩46.09b |
| Earnings | -₩22.78b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.15k |
| Gross Margin | 36.29% |
| Net Profit Margin | -35.47% |
| Debt/Equity Ratio | 163.4% |
How did A080720 perform over the long term?
See historical performance and comparison